title: Effect of food training and training dose on nicotine self-administration in rats.
abstract: Few studies investigate factors that influence acquisition in nicotine self-administration (NSA), such as food training and training dose. Most have utilized peak doses along nicotine's dose-response curve (15 and 30μg/kg) that establish NSA in the majority of animals. To investigate the specific and combined effects of training and dose on NSA acquisition, separate and head-to-head experiments using food training (FT) or spontaneous acquisition (SP) at multiple doses on the ascending limb of the dose-response curve were tested. First, rats underwent FT or SP under fixed ratio (FR1 and FR2) and progressive ratio (PR) schedules using 7.5-30μg/kg nicotine. More rats acquired NSA with FT vs. SP at 3.75μg/kg (56% vs. 38%) and 7.5μg/kg (88% vs. 40%, p<0.05) and FT rats responded higher under PR. Based on these findings, rats then underwent identical NSA acquisition and PR (with and without nicotine), extinction and reinstatement induced by cue exposure and nicotine in a head-to-head comparison of FT and SP using 7.5μg/kg. Acquisition differences were replicated: 100% FT and 60% SP rats met criteria (p<0.05). Without nicotine (cue only), no FT rats and 8% SP rats met criteria. FR and PR responding, extinction, and cue and nicotine-induced reinstatement did not differ between FT and SP. FT versus SP enhances acquisition at lower nicotine doses but does not alter subsequent behaviours. Lower doses can reinforce NSA and be used, in the absence of FT, to study influences on acquisition more closely modelling the initial phases of human smoking.
authors.affiliation: Departments of Pharmacology and Toxicology & Psychiatry, Toronto, Ontario, Canada; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
authors.forename: Kristine L P
authors.initials: KL
authors.lastname: Garcia
authors.affiliation: Departments of Pharmacology and Toxicology & Psychiatry, Toronto, Ontario, Canada; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
authors.forename: Anh Dzung
authors.initials: AD
authors.lastname: Lê
authors.affiliation: Departments of Pharmacology and Toxicology & Psychiatry, Toronto, Ontario, Canada; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada. Electronic address: r.tyndale@utoronto.ca.
authors.forename: Rachel F
authors.initials: RF
authors.lastname: Tyndale
mesh_terms: D000161:Acoustic Stimulation; D000704:Analysis of Variance; D000818:Animals; D003216:Conditioning, Operant / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D005247:Feeding Behavior / Q000187:drug effects; D005502:Food; D055103:Hypodermoclysis; D008297:Male; D009538:Nicotine / Q000008:administration & dosage / Q000494:pharmacology*; D018722:Nicotinic Agonists / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D012646:Self Administration
chemical_list: D018722:Nicotinic Agonists; D009538:Nicotine
keywords: Acquisition; Food training; Nicotine; Progressive ratio; Rat; Self-administration
references.citation: Psychopharmacology (Berl). 1997 Feb;129(3):206-14
references.pmid: 9084058
references.citation: Behav Brain Res. 2001 May;120(2):147-58
references.pmid: 11182163
references.citation: Psychopharmacology (Berl). 1995 Dec;122(4):390-94
references.pmid: 8657839
references.citation: Biol Psychiatry. 2008 Feb 1;63(3):301-8
references.pmid: 17884016
references.citation: Pharmacol Biochem Behav. 2008 Apr;89(2):227-33
references.pmid: 18230406
references.citation: Psychopharmacology (Berl). 1997 Oct;133(3):300-4
references.pmid: 9361337
references.citation: Psychopharmacology (Berl). 2002 Aug;162(4):373-8
references.pmid: 12172690
references.citation: Psychopharmacology (Berl). 1989;99(4):473-8
references.pmid: 2594913
references.citation: Eur Neuropsychopharmacol. 2009 Jul;19(7):487-98
references.pmid: 19250803
references.citation: J Pharmacol Exp Ther. 2009 Aug;330(2):633-40
references.pmid: 19448141
references.citation: Behav Brain Res. 2000 Jan;107(1-2):9-19
references.pmid: 10628726
references.citation: Pharmacol Biochem Behav. 2001 Dec;70(4):515-30
references.pmid: 11796151
references.citation: Drug Alcohol Depend. 2012 Jul 1;124(1-2):63-9
references.pmid: 22243759
references.citation: Psychopharmacology (Berl). 1998 Feb;135(4):416-22
references.pmid: 9539267
references.citation: Neuropharmacology. 2008 Oct;55(5):712-6
references.pmid: 18588903
references.citation: Psychopharmacology (Berl). 1997 Jan;129(1):35-43
references.pmid: 9122361
references.citation: Br J Pharmacol. 1984 Sep;83(1):49-55
references.pmid: 6487896
references.citation: Psychopharmacology (Berl). 2008 Mar;197(1):45-58
references.pmid: 18040666
references.citation: Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4321-6
references.pmid: 10760299
references.citation: Behav Pharmacol. 2012 Dec;23(8):781-9
references.pmid: 23080311
references.citation: Psychopharmacology (Berl). 1999 Nov;147(2):135-42
references.pmid: 10591880
references.citation: Psychopharmacology (Berl). 1998 Mar;136(1):83-90
references.pmid: 9537686
references.citation: Psychopharmacology (Berl). 2007 Feb;190(3):269-319
references.pmid: 16896961
references.citation: Psychopharmacology (Berl). 2006 Mar;184(3-4):353-66
references.pmid: 16240165
references.citation: Psychopharmacology (Berl). 2002 Sep;163(2):230-7
references.pmid: 12202970
references.citation: Pharmacol Biochem Behav. 1993 Jul;45(3):539-48
references.pmid: 8332614
references.citation: Psychopharmacology (Berl). 2010 Jul;211(1):43-54
references.pmid: 20437028
references.citation: Psychopharmacology (Berl). 2001 Aug;157(1):31-9
references.pmid: 11512040
references.citation: Neuropsychopharmacology. 2007 Mar;32(3):700-9
references.pmid: 16794562
references.citation: Int J Neuropsychopharmacol. 2009 Nov;12(10):1355-66
references.pmid: 19366487
references.citation: J Pharmacol Exp Ther. 1978 Mar;204(3):547-57
references.pmid: 633066
references.citation: Psychopharmacology (Berl). 2003 Aug;169(1):68-76
references.pmid: 12774186